- Home
- ARAI vs PLUR Comparison
ARAI vs PLUR Comparison
Compare ARAI & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARAI | PLUR |
|---|---|---|
| Founded | 2020 | 2001 |
| Country | United States | Israel |
| Employees | 51 | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.3M | 36.3M |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | ARAI | PLUR |
|---|---|---|
| Price | $0.46 | $2.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | $12.00 |
| AVG Volume (30 Days) | ★ 1.1M | 15.0K |
| Earning Date | 04-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,336,000.00 |
| Revenue This Year | $800.66 | $97.38 |
| Revenue Next Year | $650.00 | $293.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 309.82 |
| 52 Week Low | $0.50 | $2.22 |
| 52 Week High | $15.50 | $5.96 |
Technical Indicators
Market Signals| Indicator | ARAI | PLUR |
|---|---|---|
| Relative Strength Index (RSI) | 31.21 | 33.53 |
| Support Level | N/A | $2.22 |
| Resistance Level | $0.78 | $2.60 |
| Average True Range (ATR) | 0.06 | 0.19 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 19.34 | 13.73 |
Price Performance
Historical ComparisonAbout ARAI Arrive AI Inc.
Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advance chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.